Quantum Computing in Healthcare Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Component ; By Technology ; By Deployment ; By End User ; By Application ; By Region

Description

Global Quantum Computing in Healthcare Market Size Zooming 12X to Touch USD 749.71 Million by 2029

Global Quantum Computing in Healthcare Market is flourishing because of increasing investments in the research and development of quantum computing and personalized medicine.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Quantum Computing in Healthcare Market size at USD 60.71 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the Global Quantum Computing in Healthcare Market size to grow at a robust CAGR of 43.2% reaching a value of USD 749.71 million by 2029. Major growth drivers for the Global Quantum Computing in Healthcare Market include growing preference for quantum solutions among payers and a spurring demand for personalized medicine. Funding surges in quantum computing startups further fuel market expansion. Precision medicine, personalized treatments, and genomics research drive demand for advanced computational tools, with quantum computing offering unmatched power for genetic disease prediction and tailored treatment plans. Quantum computing's potential to optimize medical imaging techniques enhances diagnostic capabilities, improving image quality for accurate diagnoses. Its capacity to optimize healthcare processes drives market growth, allowing providers to enhance efficiency and streamline patient care. However, high cost for quantum computing is anticipated to restrain the overall market growth during the period in analysis.

Impact of Geopolitics on the Global Quantum Computing in Healthcare Market

The Global Quantum Computing in Healthcare Market has been significantly impacted by intensifying geopolitical disruptions in recent times. For instance, the ongoing Russia-Ukraine conflict has disrupted supply chains and hindered the production of crucial healthcare components like quantum computers and sensors. Helium, a key component in superconducting quantum computers, previously procured from Russian suppliers, poses a heightened risk, thereby compounding challenges in the interconnected global supply chain. In addition, the sanctions imposed on Russia by the United States and other countries can limit the movement of raw materials, leading to potential shortages. Beyond the war zones and disputed areas, the ongoing crisis jeopardizes a talent pool necessary for advancing healthcare quantum computing hindering collaboration between Russian physicists and Ukrainian universities renowned for their contributions.

Despite the current challenges posed by geopolitical tensions, there are potential growth opportunities for the Global Quantum Computing in Healthcare Market. The ongoing crisis underscores vulnerabilities in quantum technologies and the reliance on classical systems like GPS. Advances in quantum-resistant solutions, exemplified by ColdQuanta's innovations, provide secure and accurate healthcare solutions. These technologies can aid the industry in navigating challenges, ensuring continued resilience in the healthcare sector.

Global Quantum Computing in Healthcare Market - By Component

Based on component, the Global Quantum Computing in Healthcare Market is divided into Hardware, Software, and Services segments. The software segment holds the highest share in the Global Quantum Computing in Healthcare Market by component. Utilizing the processing capabilities of quantum computing devices and implementing specialized quantum algorithms for medical applications necessitates the indispensable role of software. To unlock the full potential of quantum computers in healthcare, researchers, scientists, and developers must have access to programming languages, quantum software frameworks, and development tools. Quantum software proves instrumental for healthcare professionals in evaluating genetic data, enhancing drug discovery processes, and addressing optimization challenges in healthcare delivery. Access to advanced programming tools and software frameworks is essential for harnessing the transformative capabilities of quantum computing in medical contexts, ensuring the efficient utilization of quantum algorithms for improved genetic analysis, drug development, and healthcare optimization.

Global Quantum Computing in Healthcare Market - By Region

The in-depth research report on the Global Quantum Computing in Healthcare Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America holds the highest share in the Global Quantum Computing in Healthcare Market, due to the robust financial support, cutting-edge expertise, and collaborative efforts between academic and industrial sectors. Also, there is a rising interest in quantum computing and its diverse applications, including healthcare. Notably, significant investments in research and development of quantum technology by the United States and Canada in the region may act as a catalyst for the expansion of quantum computing in the healthcare domain.

Competitive Landscape

Major players operating in the Global Quantum Computing in Healthcare Market include IBM Corporation, RIGETTI COMPUTING, INC., ID Quantique SA, D-Wave Systems Inc., Google LLC (Alphabet Inc.), Protiviti Inc., Deloitte Touche Tohmatsu Limited, Accenture PLC, and Atos Group. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Quantum Computing in Healthcare Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Quantum Computing in Healthcare Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC23987

1. Research Framework

1.1. Research Objective
1.2. Application Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Quantum Computing in Healthcare Market Insights

3.1. Industry Value Chain Analysis
- 3.1.1. DROC Analysis
- 3.1.2. Growth Drivers
  - 3.1.2.1. Increasing investment in quantum computing
  - 3.1.2.2. Personalized medicine
- 3.1.3. Restraints
  - 3.1.3.1. High costs
- 3.1.4. Opportunities
  - 3.1.4.1. New therapies and cures
  - 3.1.4.2. Partnerships and Collaborations
- 3.1.5. Challenges
  - 3.1.5.1. Ethical and regulatory concerns
3.2. Technological Advancement/Recent Developments
3.3. Regulatory Framework
3.4. Porter's Five Forces Analysis
- 3.4.1. Bargaining Power of Suppliers
- 3.4.2. Bargaining Power of Buyers
- 3.4.3. Threat of New Entrants
- 3.4.4. Threat of Substitutes
- 3.4.5. Intensity of Rivalry

4. Global Quantum Computing in Healthcare Market Overview

4.1. Market Application & Forecast, 2019-2029
- 4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
- 4.2.1. By Component
  - 4.2.1.1. Hardware
  - 4.2.1.2. Software
  - 4.2.1.3. Services
- 4.2.2. By Technology
  - 4.2.2.1. Superconducting Qubits
  - 4.2.2.2. Trapped Ions
  - 4.2.2.3. Quantum Annealing
  - 4.2.2.4. Others
- 4.2.3. By Deployment
  - 4.2.3.1. On-premise
  - 4.2.3.2. Cloud-based
- 4.2.4. By End User
  - 4.2.4.1. Pharmaceutical & Biopharmaceutical Companies
  - 4.2.4.2. Labs & Research Institutes
  - 4.2.4.3. Healthcare Providers
  - 4.2.4.4. Healthcare Payers
- 4.2.5. By Application
  - 4.2.5.1. Drug Discovery & Development
  - 4.2.5.2. Medical Diagnostics
  - 4.2.5.3. Genomics & Precision Medicine
  - 4.2.5.4. Radiotherapy
  - 4.2.5.5. Risk Analysis
  - 4.2.5.6. Others
- 4.2.6. By Region
  - 4.2.6.1. North America
  - 4.2.6.2. Europe
  - 4.2.6.3. Asia Pacific (APAC)
  - 4.2.6.4. Latin America (LATAM)
  - 4.2.6.5. Middle East and Africa (MEA)

5. North America Quantum Computing in Healthcare Market

5.1. Market Application & Forecast, 2019-2029
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Component
- 5.2.2. By Technology
- 5.2.3. By Deployment
- 5.2.4. By End User
- 5.2.5. By Application
- 5.2.6. By Country
  - 5.2.6.1. United States
  - 5.2.6.1.1. By Component
  - 5.2.6.1.2. By Technology
  - 5.2.6.1.3. By Deployment
  - 5.2.6.1.4. By End User
  - 5.2.6.1.5. By Application
  - 5.2.6.2. Canada
  - 5.2.6.2.1. By Component
  - 5.2.6.2.2. By Technology
  - 5.2.6.2.3. By Deployment
  - 5.2.6.2.4. By End User
  - 5.2.6.2.5. By Application

6. Europe Quantum Computing in Healthcare Market

6.1. Market Application & Forecast, 2019-2029
- 6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
- 6.2.1. By Component
- 6.2.2. By Technology
- 6.2.3. By Deployment
- 6.2.4. By End User
- 6.2.5. By Application
- 6.2.6. By Country
  - 6.2.6.1. Germany
  - 6.2.6.1.1. By Component
  - 6.2.6.1.2. By Technology
  - 6.2.6.1.3. By Deployment
  - 6.2.6.1.4. By End User
  - 6.2.6.1.5. By Application
  - 6.2.6.2. United Kingdom
  - 6.2.6.2.1. By Component
  - 6.2.6.2.2. By Technology
  - 6.2.6.2.3. By Deployment
  - 6.2.6.2.4. By End User
  - 6.2.6.2.5. By Application
  - 6.2.6.3. Italy
  - 6.2.6.3.1. By Component
  - 6.2.6.3.2. By Technology
  - 6.2.6.3.3. By Deployment
  - 6.2.6.3.4. By End User
  - 6.2.6.3.5. By Application
  - 6.2.6.4. France
  - 6.2.6.4.1. By Component
  - 6.2.6.4.2. By Technology
  - 6.2.6.4.3. By Deployment
  - 6.2.6.4.4. By End User
  - 6.2.6.4.5. By Application
  - 6.2.6.5. Spain
  - 6.2.6.5.1. By Component
  - 6.2.6.5.2. By Technology
  - 6.2.6.5.3. By Deployment
  - 6.2.6.5.4. By End User
  - 6.2.6.5.5. By Application
  - 6.2.6.6. Belgium
  - 6.2.6.6.1. By Component
  - 6.2.6.6.2. By Technology
  - 6.2.6.6.3. By Deployment
  - 6.2.6.6.4. By End User
  - 6.2.6.6.5. By Application
  - 6.2.6.7. Russia
  - 6.2.6.7.1. By Component
  - 6.2.6.7.2. By Technology
  - 6.2.6.7.3. By Deployment
  - 6.2.6.7.4. By End User
  - 6.2.6.7.5. By Application
  - 6.2.6.8. The Netherlands
  - 6.2.6.8.1. By Component
  - 6.2.6.8.2. By Technology
  - 6.2.6.8.3. By Deployment
  - 6.2.6.8.4. By End User
  - 6.2.6.8.5. By Application
  - 6.2.6.9. Rest of Europe
  - 6.2.6.9.1. By Component
  - 6.2.6.9.2. By Technology
  - 6.2.6.9.3. By Deployment
  - 6.2.6.9.4. By End User
  - 6.2.6.9.5. By Application

7. Asia Pacific Quantum Computing in Healthcare Market

7.1. Market Application & Forecast, 2019-2029
- 7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
- 7.2.1. By Component
- 7.2.2. By Technology
- 7.2.3. By Deployment
- 7.2.4. By End User
- 7.2.5. By Application
- 7.2.6. By Country
  - 7.2.6.1. China
  - 7.2.6.1.1. By Component
  - 7.2.6.1.2. By Technology
  - 7.2.6.1.3. By Deployment
  - 7.2.6.1.4. By End User
  - 7.2.6.1.5. By Application
  - 7.2.6.2. India
  - 7.2.6.2.1. By Component
  - 7.2.6.2.2. By Technology
  - 7.2.6.2.3. By Deployment
  - 7.2.6.2.4. By End User
  - 7.2.6.2.5. By Application
  - 7.2.6.3. Japan
  - 7.2.6.3.1. By Component
  - 7.2.6.3.2. By Technology
  - 7.2.6.3.3. By Deployment
  - 7.2.6.3.4. By End User
  - 7.2.6.3.5. By Application
  - 7.2.6.4. South Korea
  - 7.2.6.4.1. By Component
  - 7.2.6.4.2. By Technology
  - 7.2.6.4.3. By Deployment
  - 7.2.6.4.4. By End User
  - 7.2.6.4.5. By Application
  - 7.2.6.5. Australia & New Zealand
  - 7.2.6.5.1. By Component
  - 7.2.6.5.2. By Technology
  - 7.2.6.5.3. By Deployment
  - 7.2.6.5.4. By End User
  - 7.2.6.5.5. By Application
  - 7.2.6.6. Indonesia
  - 7.2.6.6.1. By Component
  - 7.2.6.6.2. By Technology
  - 7.2.6.6.3. By Deployment
  - 7.2.6.6.4. By End User
  - 7.2.6.6.5. By Application
  - 7.2.6.7. Malaysia
  - 7.2.6.7.1. By Component
  - 7.2.6.7.2. By Technology
  - 7.2.6.7.3. By Deployment
  - 7.2.6.7.4. By End User
  - 7.2.6.7.5. By Application
  - 7.2.6.8. Singapore
  - 7.2.6.8.1. By Component
  - 7.2.6.8.2. By Technology
  - 7.2.6.8.3. By Deployment
  - 7.2.6.8.4. By End User
  - 7.2.6.8.5. By Application
  - 7.2.6.9. Vietnam
  - 7.2.6.9.1. By Component
  - 7.2.6.9.2. By Technology
  - 7.2.6.9.3. By Deployment
  - 7.2.6.9.4. By End User
  - 7.2.6.9.5. By Application
  - 7.2.6.10. Rest of APAC
  - 7.2.6.10.1. By Component
  - 7.2.6.10.2. By Technology
  - 7.2.6.10.3. By Deployment
  - 7.2.6.10.4. By End User
  - 7.2.6.10.5. By Application

8. Latin America Quantum Computing in Healthcare Market

8.1. Market Application & Forecast, 2019-2029
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.1. By Component
- 8.2.2. By Technology
- 8.2.3. By Deployment
- 8.2.4. By End User
- 8.2.5. By Application
- 8.2.6. By Country
  - 8.2.6.1. Brazil
  - 8.2.6.1.1. By Component
  - 8.2.6.1.2. By Technology
  - 8.2.6.1.3. By Deployment
  - 8.2.6.1.4. By End User
  - 8.2.6.1.5. By Application
  - 8.2.6.2. Mexico
  - 8.2.6.2.1. By Component
  - 8.2.6.2.2. By Technology
  - 8.2.6.2.3. By Deployment
  - 8.2.6.2.4. By End User
  - 8.2.6.2.5. By Application
  - 8.2.6.3. Argentina
  - 8.2.6.3.1. By Component
  - 8.2.6.3.2. By Technology
  - 8.2.6.3.3. By Deployment
  - 8.2.6.3.4. By End User
  - 8.2.6.3.5. By Application
  - 8.2.6.4. Peru
  - 8.2.6.4.1. By Component
  - 8.2.6.4.2. By Technology
  - 8.2.6.4.3. By Deployment
  - 8.2.6.4.4. By End User
  - 8.2.6.4.5. By Application
  - 8.2.6.5. Rest of LATAM
  - 8.2.6.5.1. By Component
  - 8.2.6.5.2. By Technology
  - 8.2.6.5.3. By Deployment
  - 8.2.6.5.4. By End User
  - 8.2.6.5.5. By Application

9. Middle East & Africa Quantum Computing in Healthcare Market

9.1. Market Application & Forecast, 2019-2029
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Component
- 9.2.2. By Technology
- 9.2.3. By Deployment
- 9.2.4. By End User
- 9.2.5. By Application
- 9.2.6. By Country
  - 9.2.6.1. Saudi Arabia
  - 9.2.6.1.1. By Component
  - 9.2.6.1.2. By Technology
  - 9.2.6.1.3. By Deployment
  - 9.2.6.1.4. By End User
  - 9.2.6.1.5. By Application
  - 9.2.6.2. UAE
  - 9.2.6.2.1. By Component
  - 9.2.6.2.2. By Technology
  - 9.2.6.2.3. By Deployment
  - 9.2.6.2.4. By End User
  - 9.2.6.2.5. By Application
  - 9.2.6.3. Qatar
  - 9.2.6.3.1. By Component
  - 9.2.6.3.2. By Technology
  - 9.2.6.3.3. By Deployment
  - 9.2.6.3.4. By End User
  - 9.2.6.3.5. By Application
  - 9.2.6.4. Kuwait
  - 9.2.6.4.1. By Component
  - 9.2.6.4.2. By Technology
  - 9.2.6.4.3. By Deployment
  - 9.2.6.4.4. By End User
  - 9.2.6.4.5. By Application
  - 9.2.6.5. South Africa
  - 9.2.6.5.1. By Component
  - 9.2.6.5.2. By Technology
  - 9.2.6.5.3. By Deployment
  - 9.2.6.5.4. By End User
  - 9.2.6.5.5. By Application
  - 9.2.6.6. Nigeria
  - 9.2.6.6.1. By Component
  - 9.2.6.6.2. By Technology
  - 9.2.6.6.3. By Deployment
  - 9.2.6.6.4. By End User
  - 9.2.6.6.5. By Application
  - 9.2.6.7. Algeria
  - 9.2.6.7.1. By Component
  - 9.2.6.7.2. By Technology
  - 9.2.6.7.3. By Deployment
  - 9.2.6.7.4. By End User
  - 9.2.6.7.5. By Application
  - 9.2.6.8. Rest of MEA
  - 9.2.6.8.1. By Component
  - 9.2.6.8.2. By Technology
  - 9.2.6.8.3. By Deployment
  - 9.2.6.8.4. By End User
  - 9.2.6.8.5. By Application

10. Competitive Landscape

10.1. List of Key Players and Their Materials
10.2. Global Quantum Computing in Healthcare Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Quantum Computing in Healthcare Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

12.1. IBM Corporation
12.2. RIGETTI COMPUTING, INC.
12.3. ID Quantique SA
12.4. D-Wave Systems Inc.
12.5. Google LLC (Alphabet Inc.)
12.6. Protiviti Inc.
12.7. Deloitte Touche Tohmatsu Limited
12.8. Accenture PLC
12.9. Atos Group
12.10. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations